Evid Based Nurs doi:10.1136/eb-2012-101002
  • Midwifery
  • Cohort study

Use of antidepressants in the second trimester is associated with reduced pregnancy duration, and third trimester antidepressant use with infant convulsions

  1. Jennifer L Payne
  1. Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
  1. Correspondence to: Dr Jennifer L Payne
    Department of Psychiatry, Johns Hopkins School of Medicine, 550 N. Broadway, Suite 305, Baltimore, MD 21205, USA; jpayne5{at}

Commentary on:

Implications for practice and research

  • Second trimester exposure to antidepressants was associated with preterm birth.

  • Third trimester exposure was associated with infant convulsions.

  • The absolute risk for both outcomes is extremely low and most infants will not have these complications.

  • Decisions about whether to use antidepressants during pregnancy should include the severity of the mother's psychiatric illness.

  • Large studies that include severity of the mother's illness need to be conducted.


Approximately 10–20% of women will meet the criteria for major depressive disorder (MDD) during their lifetime, including during pregnancy.1 Rates of antidepressant exposure …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article